InvestorsHub Logo
icon url

sleekscape

10/09/22 10:50 PM

#30101 RE: fichni #30100

Schedule II is untenable from a practical standpoint because only physicians can prescribe Schedule II substances, which would mean that all recreational sellers and recreational users are continuing to break federal law

Creation of a novel schedule or complete descheduling (with certain caveats) and treating MJ more akin to alcohol is the more likely outcome

Leaving MJ as a Schedule I substance entirely defeats the purpose of Biden’s request to evaluate its present scheduling status

Five states will be voting on Rec MJ Legalization in November and four of them are Republican states:

https://www.reuters.com/world/us/voters-five-us-states-decide-legalizing-marijuana-november-midterms-2022-10-07/

It remains to be seen if Biden’s schedule reviewal order and a handful of new red states with legal Rec MJ after the November elections will sway a bunch of Republicans in the Senate to vote for an edited version of Chuck’s bill, but the probability of that occurrence has certainly increased

If Chuck’s bill remains a no-go after elections, SAFE+ is sitting right there waiting to be passed

With the MJ sector currently bottomed out, that leaves the sole negative factor of overall market sentiment, which is admittedly very poor

But in terms of risk/reward ratio, this looks like a more than reasonable entry point barring a nuclear war.


Sleek